Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26115617 | 1.00 | AR (0.62) | ARCRBN | |
| SCHEMBL25937180 | 1.00 | AR (0.62) | ARCRBN | |
| SCHEMBL19600787 | 0.92 | AR (0.64) | ARCRBN | |
| SCHEMBL24379225 | 0.91 | AR (0.54) | ARCRBN | |
| SCHEMBL20046374 | 0.91 | AR (0.59) | ARCRBN | |
| SCHEMBL26116944 | 0.91 | AR (0.64) | ARCRBN | |
| SCHEMBL25141463 | 0.91 | AR (0.64) | ARCRBN | |
| SCHEMBL30588309 | 0.91 | AR (0.64) | ARCRBN | |
| SCHEMBL25141595 | 0.90 | AR (0.62) | ARCRBN | |
| SCHEMBL30588422 | 0.90 | AR (0.62) | ARCRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499628-A1 | 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024054953-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |
| WO-2023180388-A1 | 2,4-DIOXOTETRAHYDROPYRIMIDINYL DERIVATIVES AS DEGRONS IN PROTACS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2023-09-28 | — | — | WO | disclosed |
| WO-2022025640-A1 | COMPOUND FOR INHIBITING OR DISINTEGRATING ANDROGEN RECEPTOR, AND PHARMACEUTICAL USE THEREOF | 한국화학연구원 | 2022-02-03 | — | — | WO | disclosed |